Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

International Journal of Epidemiology

Volumn 45, Issue 5, 2016, Pages 1458-1468

  Nelson, Shakira M ^a   Panagiotou, Orestis A ^a   Anic, Gabriella M ^a   Mondul, Alison M ^b   Männistö, Satu ^c   Weinstein, Stephanie J ^a   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

25 hydroxy vitamin D; Amino acids; CMPF; Fatty acids; Lipids; Metabolomics; Serum metabolites

Indexed keywords

1 PALMITOYLGLYCEROL; 2 PALMITOYLGLYCEROL; 25 HYDROXYVITAMIN D; 3 CARBOXY 4 METHYL 5 PROPYL 2 FURANPROPANOIC ACID; 3 HYDROXYSEBACATE; ALPHA TOCOPHEROL; AMINO ACID; BETA CAROTENE; CAMPESTEROL; CAPRATE; CARBOHYDRATE; CYSTEINE; DOCOSAHEXAENOIC ACID; EPIANDROSTERONE SULFATE; ERUCOYL SPHINGOMYELIN; GLUTAMIC ACID; HEXANOYLGLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; METHIONINE; MYRISTOLEATE; OCTANOIC ACID; PALIMITOYL OLEOYL GLYCEROPHOSPHOGLYCEROL 2; PALMITOYLCARNITINE; PEPTIDE; PREGNENOLONE SULFATE; RETINOL; STEAROYL ARACHIDONOYL GLYCEROPHOSPHOETHANOLAMINE; TESTOSTERONE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; 25-HYDROXYVITAMIN D; 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPANOIC ACID; FATTY ACID; FURAN DERIVATIVE; PROPIONIC ACID DERIVATIVE; VITAMIN D;

AMINO ACID; BONE; CANCER; CHEMICAL ANALYSIS; ETIOLOGY; FATTY ACID; LIPID; METABOLISM; METABOLITE; PUBLIC HEALTH; SERUM; VITAMIN;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; DIETARY SUPPLEMENT; EPIDEMIOLOGY; FINLAND; MULTIVARIATE ANALYSIS; NEOPLASM; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STATISTICAL MODEL;

AGED; ALPHA-TOCOPHEROL; AMINO ACIDS; BETA CAROTENE; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FATTY ACIDS; FINLAND; FURANS; HUMANS; LINEAR MODELS; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROPIONATES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SMOKING; VITAMIN D;

EID: 85020584152     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw148     Document Type: Article

References (54)

1. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-85
2. Christakos S, DeLuca HF. Minireview: Vitamin D: is there a role in extraskeletal health?. Endocrinology 2011;152:2930-6
3. Christakos S, Seth T, Hirsch J, Porta A, Moulas A, Dhawan P. Vitamin D biology revealed through the study of knockout and transgenic mouse models. Annu Rev Nutr 2013;33:71-85
4. Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives frommice andman. J BoneMinerRes 2008;23:974-9
5. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am 2010;39:255-69, Table of Contents
6. Albanes D. Vitamin D and Cancer: Diversity, complexity, and still a ways to go. Cancer Prevention Research 2015;8:657-61
7. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012;32:2794-802
8. Chowdhury R, Kunutsor S, Vitezova A et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014;348:g1903
9. Brondum-Jacobsen P, Benn M, Afzal S, Nordestgaard BG. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Int J Epidemiol 2015;44:651-61
10. Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts. BMJ 2014;349:g6330
11. Lee JE, Li H, Chan AT et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prevention Research 2011;4:735-43
12. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014;14:342-57
13. Xu Y, Shao X, Yao Yet al. Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis. J Cancer Res Clin Oncol 2014;140:1465-77
14. Albanes D, Mondul AM, Yu K et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev 2011;20:1850-60
15. Kristal AR, Till C, Song X et al. Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2014;23:1494-504
16. Schenk JM, Till CA, Tangen CM et al. Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 2014;23:1484-93
17. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012;13: 263-9
18. Sampson JN, Boca SM, Shu XO et al. Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev 2013;22:631-40
19. The ATBC Cancer Prevention Study Group. The alphatocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10
20. Tangrea J, Helzlsouer K, Pietinen P et al. Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 1997;8:615-25
21. Freedman DM, Tangrea JA, Virtamo J, Albanes D. The effect of beta-carotene supplementation on serum vitamin D metabolite concentrations. Cancer Epidemiol Biomarkers Prev 1999;8: 1115-16
22. Weinstein SJ, Mondul AM, KoppW, Rager H, Virtamo J, Albanes D. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer. Int J Cancer 2013;132:2940-7
23. Lim U, Freedman DM, Hollis BW et al. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Cancer Epidemiol Biomarkers Prev 2009;124:979-86
24. Faupel-Badger JM, Diaw L, Albanes D, Virtamo J, Woodson K, Tangrea JA. Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men. Cancer Epidemiol Biomarkers Prev 2007;16: 2784-6
25. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/ electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009;81:6656-67
26. Mondul AM, Sampson JN, Moore SC et al. Metabolomic profile of response to supplementation with beta-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 2013;98:488-93
27. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. Journal of Cheminformatics 2010;2:9
28. Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Metabolomic analysis of prostate cancer risk in a prospective cohort: The Alpha-Tocolpherol, Beta-Carotene Cancer Prevention (ATBC) study. Int J Cancer 2015;137: 2124-32
29. Prentice KJ, Luu L, Allister EM et al. The furan fatty acid metabolite CMPF is elevated in diabetes and induces beta cell dysfunction. Cell Metabolism 2014;19:653-66
30. Lankinen MA, Hanhineva K, KolehmainenMet al. CMPF does not associate with impaired glucose metabolism in individuals with features ofmetabolic syndrome. PloS One 2015;10:e0124379
31. Tsujimoto M, Nagano Y, Hosoda S et al. Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease. Toxins 2013;5: 1475-85
32. Volpe DA, Tobin GA, Tavakkoli F, Dowling TC, Light PD, Parker RJ. Effect of uremic serum and uremic toxins on drug metabolism in human microsomes. Regul Toxicol Pharmacol 2014;68:297-303
33. Spiteller G. Furan fatty acids: occurrence, synthesis, and reactions: are furan fatty acids responsible for the cardioprotective effects of a fish diet? Lipids 2005;40:755-71
34. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, Vilarem MJ. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 2002;277:25125-32
35. Zhou C, Assem M, Tay JC et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116:1703-12
36. Xu Y, Hashizume T, Shuhart MC et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha, 25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol 2006;69:56-65
37. Waxman DJ, Attisano C, Guengerich FP, Lapenson DP. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme. Arch Biochem Biophys 1988;263:424-36
38. Pilz S, Frisch S, Koertke H et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res 2011;43:223-5
39. Anic GM, Albanes D, Rohrmann S, et al. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men inNHANES. Clin Endocrinol (Oxf) 2016; 85: 258-66
40. Guertin KA, Moore SC, Sampson JN et al. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr 2014;100:208-17
41. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007;7:684-700
42. Lu Z, Chen TC, Zhang A et al. An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol 2007;103:642-4
43. Veret J, Bellini L, Giussani P, Ng C, Magnan C, Stunff HL. Roles of sphingolipid metabolism in pancreatic beta cell dysfunction induced by lipotoxicity. Journal of Clinical Medicine 2014;3:646-62
44. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008;29:351-66
45. Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Vitamin D concentration, obesity, and risk of diabetes: a Mendelian randomisation study. Lancet Diabetes Endocrinol 2014;2:298-306
46. Sotirchos ES, Bhargava P, Eckstein C et al. Safety and immunologic effects of high-vs low-dose cholecalciferol in multiple sclerosis. Neurology 2016;86:382-90
47. Cooney RV, Franke AA, Wilkens LR, Gill J, Kolonel LN. Elevated plasma gamma-tocopherol and decreased alphatocopherol in men are associated with inflammatory markers and decreased plasma 25-OH vitamin D. Nutr Cancer 2008;60 Suppl 1:21-9
48. Chai W, Bostick RM, Ahearn TU, Franke AA, Custer LJ, Cooney RV. Effects of vitamin D3 and calcium supplementation on serum levels of tocopherols, retinol, and specific vitamin D metabolites. Nutr Cancer 2012;64:57-64
49. Cooney RV, Franke AA, Hankin JH et al. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev 1995;4:207-15
50. Jenab M, Bueno-de-Mesquita HB, Ferrari P et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 2010;340:b5500
51. Maki KC, Rubin MR, Wong LG et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009;3:289-96
52. Chai W, Cooney RV, Franke AA, Bostick RM. Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 2013;23:564-70
53. Carlson LA, Olsson AG, Oro L, Rossner S. Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis 1971;14:391-400
54. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review andmeta-analysis. Obes Rev 2013;14:393-404